* Organon & Co is expected to show a rise in quarterly revenue when it reports results on May 2 for the period ending March 31 2024
* The Jersey City New Jersey-based company is expected to report a 1.6% increase in revenue to $1.563 billion from $1.54 billion a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
* LSEG's mean analyst estimate for Organon & Co is for earnings of 93 cents per share.
* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 4 "strong buy" or "buy," 5 "hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by about 0.3% in the last three months.
* Wall Street's median 12-month price target for Organon & Co is $21.00, above its last closing price of $18.90.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 0.81 0.83 0.88 Beat 6
Sep. 30 2023 1.05 1.06 0.87 Missed -17.7
Jun. 30 2023 0.98 1.01 1.31 Beat 30.1
Mar. 31 2023 1.17 1.16 1.08 Missed -6.9
Dec. 0.92 0.90 0.81 Missed -9.8
31 2022
Sep. 30 2022 1.13 1.09 1.32 Beat 20.7
Jun. 30 2022 1.16 1.16 1.25 Beat 8.1
Mar. 31 2022 1.30 1.30 1.65 Beat 27.1
This summary was machine generated April 30 at 16:52 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments